Joseph Edelman, 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), bought 1,200,000 shares at $19.80 ($23.8M) on 2021-10-25, disclosed to the SEC on 2021-10-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |